AccessPak for HIV PEP Expanded with Kaletra and Busulfan Concentrate Injection
Determining the interaction of AccessPak for HIV PEP Expanded with Kaletra and Busulfan Concentrate Injection and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: emtricitabine / lopinavir / ritonavir / tenofovir
Brand name: AccessPak for HIV PEP Expanded with Kaletra
Synonyms: n.a.
Generic Name: busulfan
Brand name: Busulfex, Myleran
Synonyms: Busulfan (oral/injection), Busulfan
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- AccessPak for HIV PEP Expanded with Kaletra-Busulfan Injection
- AccessPak for HIV PEP Expanded with Kaletra-Busulfan Intravenous
- AccessPak for HIV PEP Expanded with Kaletra-Busulfan oral/injection
- AccessPak for HIV PEP Expanded with Kaletra-Busulfan Tablet
- AccessPak for HIV PEP Expanded with Kaletra-Busulfex
- AccessPak for HIV PEP Expanded with Kaletra-Butabarbital
- Busulfan Concentrate Injection-AccessPak for HIV PEP Expanded with Viracept
- Busulfan Concentrate Injection-Accolate
- Busulfan Concentrate Injection-Accretropin
- Busulfan Concentrate Injection-Accucaine
- Busulfan Concentrate Injection-AccuHist Drops
- Busulfan Concentrate Injection-AccuHist PDX Drops